Form 4: ChromaDex Director Kristin Patrick Exercises Options and Sells Shares

Director Kristin Patrick exercised stock options and sold shares of ChromaDex Corp. on August 23, 2024.

Summary

• On August 23, 2024, Kristin Patrick, a director of ChromaDex Corp., exercised stock options to acquire 3,000 shares at $1.64 and 20,000 shares at $1.67.
• Following the exercise of these options, Patrick sold 23,000 shares of common stock at a weighted average price of $3.57, with prices ranging from $3.52 to $3.64.
• After these transactions, Patrick directly owns 0 shares of common stock.
• Patrick continues to hold 17,000 stock options with an exercise price of $1.64 and 0 stock options with an exercise price of $1.67.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like directors and officers, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value.

Comparison to Industry Standards

• Insider transactions are a common occurrence in publicly traded companies.
• The scale of this transaction (23,000 shares sold) is relatively small compared to insider sales at larger companies like Apple or Microsoft, where transactions can involve millions of shares.
• The exercise of options and subsequent sale of shares is a typical way for executives to monetize their stock-based compensation.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.
• However, the transaction is relatively small and unlikely to have a significant impact on the company's operations or other stakeholders.

Key Dates